20 June 2024

Multispectral imaging of 3D patient-derived organoids not only generates beautiful images but also allows for the identification of potential new targets and detection probes to recognize tumor tissue during surgery.

This EMBO molecular medicine paper highlights the 3D-imaging capacity of QVQ’s anti-NCAM single domain antibody (sdAb) Q55c, as well as for sdAbs against EGFR and HER2.

QVQ offers anti-HER2 (Q17), anti-EGFR (Q44), and other target-specific sdAb probes as unlabeled, cysteine-tagged or directionally labeled reagents.